MENU
+Compare
ONCY
Stock ticker: NASDAQ
AS OF
Jun 6, 01:44 PM (EDT)
Price
$0.34
Change
+$0.01 (+3.03%)
Capitalization
29.14M

ONCY Oncolytics Biotech Forecast, Technical & Fundamental Analysis

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company... Show more

Industry: #Biotechnology
ONCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ONCY with price predictions
Jun 05, 2025

ONCY in -4.09% downward trend, declining for three consecutive days on June 05, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where ONCY declined for three days, in of 323 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on April 30, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ONCY as a result. In of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ONCY turned negative on May 06, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at .

The Aroon Indicator for ONCY entered a downward trend on June 05, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 12 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 22 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ONCY advanced for three days, in of 200 cases, the price rose further within the following month. The odds of a continued upward trend are .

ONCY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.242) is normal, around the industry mean (16.332). P/E Ratio (0.000) is within average values for comparable stocks, (59.787). ONCY's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.227). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (263.647).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. ONCY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ONCY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
ONCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ONCY is expected to report earnings to rise 10.63% to -8 cents per share on August 06

Oncolytics Biotech ONCY Stock Earnings Reports
Q2'25
Est.
$-0.09
Q1'25
Beat
by $0.03
Q4'24
Beat
by $0.02
Q3'24
Missed
by $0.02
Q2'24
Est.
$-0.10
The last earnings report on May 14 showed earnings per share of -7 cents, beating the estimate of -10 cents. With 173.67K shares outstanding, the current market capitalization sits at 29.14M.
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products for the treatment of cancers

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
322 11th Avenue S.W
Phone
+1 403 670-7377
Employees
26
Web
https://www.oncolyticsbiotech.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IMO72.960.72
+1.00%
Imperial Oil Limited
AFRI7.850.05
+0.64%
Forafric Global PLC
AGRO9.07-0.09
-0.98%
Adecoagro SA
PAGS8.84-0.12
-1.34%
PagSeguro Digital Ltd
SNT3.86-0.17
-4.10%
Senstar Technologies Corp

ONCY and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ONCY has been loosely correlated with SRRK. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if ONCY jumps, then SRRK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ONCY
1D Price
Change %
ONCY100%
-2.09%
SRRK - ONCY
40%
Loosely correlated
+11.13%
ABCL - ONCY
33%
Loosely correlated
-2.27%
RXRX - ONCY
32%
Poorly correlated
-7.13%
ABSI - ONCY
29%
Poorly correlated
-0.35%
ZURA - ONCY
28%
Poorly correlated
-2.54%
More